Diabetes in day case general and vascular surgery: A multicentre regional audit.
Adult
Aged
Aged, 80 and over
Ambulatory Surgical Procedures
/ adverse effects
Diabetes Mellitus
/ blood
England
Female
General Surgery
/ statistics & numerical data
Glycated Hemoglobin
/ metabolism
Guideline Adherence
/ statistics & numerical data
Hospitals
/ standards
Humans
Male
Medical Audit
Middle Aged
Postoperative Complications
/ etiology
Practice Guidelines as Topic
Preoperative Care
/ standards
Vascular Surgical Procedures
/ adverse effects
Young Adult
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
23
11
2019
revised:
14
12
2019
accepted:
24
12
2019
pubmed:
31
12
2019
medline:
19
8
2020
entrez:
30
12
2019
Statut:
ppublish
Résumé
People with Diabetes Mellitus (DM) are at increased risk of postoperative complications if their HbA1C readings are not well controlled. In the UK, there are clear national guidelines requiring all people with DM to have HbA1C blood testing within 6months before undergoing surgery and that these readings should be below 69 mmol/mol if this is safe to achieve. The aim of this study was to determine whether hospitals in the region were compliant with the guidelines. Data were prospectively collected from seven hospitals across the East of England region from 1st October 2017 to 31st March 2018 (6 months) in all people with DM undergoing elective day case procedures in General and Vascular surgery for benign disease. A total of 181 people with DM were included in the study, of whom 77.9% were male patients and the median age was 63 years. The three most commonly performed operations were laparoscopic cholecystectomy (20.9%, n = 38/181), inguinal hernia repair (20.4%, n = 37/181) and umbilical/para-umbilical hernia repair (11.0%, n = 20/181). In keeping with the national guidelines, only 86.7% (n = 157/181) of patients had an HbA1C tested within 6 months prior to their surgery date. Of the patients who had a preoperative HbA1C, 14 (n = 14/157, 8.9%) had an HbA1C ≥ 69 mmol/mol, and 12 (n = 12/14, 85.7%) of these proceeded to surgery without optimisation of their HbA1C. A significant proportion of people with diabetes undergoing elective day case procedures in our region do not have HbA1C testing within 6 months of their procedure as recommended by the national guidelines. In patients who do have a high HbA1C, the majority still undergo surgery without adequate control of their DM. Greater awareness amongst healthcare workers and robust pathways are required for this vulnerable group of patients if we are to reduce the risk of developing postoperative complication rates.
Sections du résumé
BACKGROUND
BACKGROUND
People with Diabetes Mellitus (DM) are at increased risk of postoperative complications if their HbA1C readings are not well controlled. In the UK, there are clear national guidelines requiring all people with DM to have HbA1C blood testing within 6months before undergoing surgery and that these readings should be below 69 mmol/mol if this is safe to achieve. The aim of this study was to determine whether hospitals in the region were compliant with the guidelines.
METHODS
METHODS
Data were prospectively collected from seven hospitals across the East of England region from 1st October 2017 to 31st March 2018 (6 months) in all people with DM undergoing elective day case procedures in General and Vascular surgery for benign disease.
RESULTS
RESULTS
A total of 181 people with DM were included in the study, of whom 77.9% were male patients and the median age was 63 years. The three most commonly performed operations were laparoscopic cholecystectomy (20.9%, n = 38/181), inguinal hernia repair (20.4%, n = 37/181) and umbilical/para-umbilical hernia repair (11.0%, n = 20/181). In keeping with the national guidelines, only 86.7% (n = 157/181) of patients had an HbA1C tested within 6 months prior to their surgery date. Of the patients who had a preoperative HbA1C, 14 (n = 14/157, 8.9%) had an HbA1C ≥ 69 mmol/mol, and 12 (n = 12/14, 85.7%) of these proceeded to surgery without optimisation of their HbA1C.
CONCLUSION
CONCLUSIONS
A significant proportion of people with diabetes undergoing elective day case procedures in our region do not have HbA1C testing within 6 months of their procedure as recommended by the national guidelines. In patients who do have a high HbA1C, the majority still undergo surgery without adequate control of their DM. Greater awareness amongst healthcare workers and robust pathways are required for this vulnerable group of patients if we are to reduce the risk of developing postoperative complication rates.
Substances chimiques
Glycated Hemoglobin A
0
hemoglobin A1c protein, human
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13472Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Public Health England. Diabetes Prevalence Model; 2016. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/612306/Diabetesprevalencemodelbriefing.pdf
Pournaras DJ, Photi ES, Barnett N, et al. Assessing the quality of primary care referrals to surgery of patients with diabetes in the East of England: a multi-centre cross-sectional cohort study. Int J Clin Pract. 2017;71:e12971. https://doi.org/10.1111/ijcp.12971.
Barker P, Creasey PE, Dhatariya K, et al.; Membership of the Working Party. Peri-operative management of the surgical patient with diabetes 2015. Anaesthesia. 2015;70(12):1427-1440
Public Health England. Adult obesity and type 2 diabetes; 2014. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/338934/Adult_obesity_and_type_2_diabetes_pdf
Walid MS, Newman BF, Yelverton JC, et al. Prevalence of previously unknown elevation of glycosylated hemoglobin in spine surgery patients and impact on length of stay and total cost. J Hosp Med. 2010;5:E10-E14. https://doi.org/10.1002/jhm.541
O'Sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006;32:188-197. https://doi.org/10.1016/j.ejvs.2006.01.011
Sadoskas D, Suder NC, Wukich DK. Perioperative glycemic control and the effect on surgical site infections in diabetic patients undergoing foot and ankle surgery. Foot Ankle Spec. 2016;9:24-30. https://doi.org/10.1177/1938640015593077.
Domek N, Dux K, Pinzur M., et al. Association between hemoglobin A1c and surgical morbidity in elective foot and ankle surgery. J Foot Ankle Surg. 2016;55:939-943. https://doi.org/10.1053/j.jfas.2016.04.009
Jehan F, Khan M, Sakran JV, et al. Perioperative glycemic control and postoperative complications in patients undergoing emergency general surgery: What is the role of Plasma Hemoglobin A1c? J Trauma Acute Care Surg. 2018;84:112-117. https://doi.org/10.1097/TA.0000000000001724
Martin ET, Kaye KS, Knott C, et al. Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37:88-99. https://doi.org/10.1017/ice.2015.249
Gustafsson UO, Thorell A, Soop M, Ljungqvist O, Nygren J. Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Brit J Surg. 2009;96:1358-1364. https://doi.org/10.1002/bjs.6724
Halkos ME, Lattouf OM, Puskas JD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg. 2008;86:1431-1437. https://doi.org/10.1016/j.athoracsur.2008.06.078
Kreutziger J, Schlaepfer J, Wenzel V, Constantinescu MA. The role of admission blood glucose in outcome prediction of surviving patients with multiple injuries. J Trauma. 2009;67:704-708. https://doi.org/10.1097/TA.0b013e3181b22e37.
Vilar-Compte D, Álvarez de Iturbe I, Martín-Onraet A, Pérez-Amador M, Sánchez-Hernández C, Volkow P. Hyperglycemia as a risk factor for surgical site infections in patients undergoing mastectomy. Am J Infect Control. 2008;36:192-198. https://doi.org/10.1016/j.ajic.2007.06.003
Park C, Hsu C, Neelakanta G, et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation. 2009;87:1031-1036. https://doi.org/10.1097/TP.0b013e31819cc3e6
Ambiru S, Kato A, Kimura F, et al. Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan. J Hosp Infect. 2008;68:230-233. https://doi.org/10.1016/j.jhin.2007.12.002
Chuang S-C, Lee K-T, Chang W-T, et al. Risk factors for wound infection after cholecystectomy. J Formos Med Assoc. 2004;103:607-612.
Shibuya N, Humphers JM, Fluhman BL, Jupiter DC. Factors associated with nonunion, delayed union, and malunion in and ankle surgery in diabetic patients. J Foot Ankle Surg. 2013;52:207-211. https://doi.org/10.1053/j.jfas.2012.11.012
Association of British Clinical Diabetologists. Joint British Diabetes Societies (JBDS) for Inpatient Care Group; 2019. https://abcd.care/sites/abcd.care/files/resources/Surgical_guidelines_2015_full_FINAL_amended_Mar_2016.pdf
World Health Organization. Global report on diabetes. IJNCD. 2016;2016:3-8.
Wang J, Chen K, Li X, et al. Postoperative adverse events in patients with diabetes undergoing orthopedic and general surgery. Medicine. 2019;98:e15089. https://doi.org/10.1097/MD.0000000000015089
Worley N, Buza J, Jalai CM, et al. Diabetes as an independent predictor for extended length of hospital stay and increased adverse post-operative events in patients treated surgically for cervical spondylotic myelopathy. Int J Spine Surg. 2017;11:10. https://doi.org/10.14444/4010
Passias PG, Jalai CM, Worley N, et al. Predictors of hospital length of stay and 30-day readmission in cervical spondylotic myelopathy patients: an analysis of 3057 patients using the ACS-NSQIP database. World Neurosurg. 2018;110:e450-e458. https://doi.org/10.1016/j.wneu.2017.11.009
Grocott MPW, Edwards M, Mythen M, Aronson S. Peri-operative care pathways: re-engineering care to achieve the ‘triple aim'. Anaethesia. 2019;74:90-99. https://doi.org/10.1111/anae.14513
Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff. 2008;27:759-769.
NHS England. Next steps on the NHS Five Year Forward View; 2017. https://www.england.nhs.uk/publication/next-steps-on-the-nhs-five-year-forward-view (accessed 10/12/2019).
Uppal C, Blanshard A, Ahluwalia R, Dhatariya K. Achieving a preoperative target HbA1c of < 69 mmol/mol in elective vascular and orthopedic surgery: a retrospective single center observational study. Diabetes Ther. 2019;10:1959-1967. https://doi.org/10.1007/s13300-019-00688-x